PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Recruiting N/A Interventional Study
NSCLC Stage II NSCLC, Stage III
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
University of Utah · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ages 18 and older at time of diagnosis * Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC) * Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery * Patient able to follow direction and complete questionnaires in English or Span…
Contacts

Thomas Varghese, MD, MS, MBA, FACS

801-581-5311

thomas.varghese@hsc.utah.edu

CONTACT

Cornelia Ulrich, MS, PhD

801-213-5716

neli.ulrich@hci.utah.edu

CONTACT